Gujarat Updates Essential Drugs List for 2025–26
The Gujarat government has revised its Essential Drugs List for the financial year 2025–26, increasing the total number of medicines and medical supplies available in public healthcare facilities. The updated list now contains 1,479 medicines, surgical items, and diagnostic supplies, reflecting the government’s effort to strengthen access to essential treatment across the state.
150 Medicines Added and 57 Removed
As part of the revision, the state added 150 new medicines while removing 57 drugs considered outdated, unnecessary, or duplicative. The update followed a detailed review by experts to ensure that the list remains aligned with current treatment protocols and evolving healthcare needs.
This change represents a net increase compared with the previous year’s list of 1,386 items, expanding the availability of essential treatments for patients in government health facilities.
Understanding the Essential Drugs List
The Essential Drugs List is a curated list of medicines considered critical for treating common and serious diseases. It forms the backbone of Gujarat’s free drug program and is managed by the Gujarat Medical Services Corporation Limited (GMSCL).
Under this system, medicines listed in the EDL are provided free of cost at government health facilities including primary health centres, community health centres, district hospitals, and medical college hospitals. This initiative aims to reduce out of pocket expenditure for patients while improving treatment accessibility.
Distribution Across Levels of Healthcare
The medicines included in the list are distributed based on the level of healthcare delivery to ensure efficient supply.
At the primary care level, around 378 medicines are available to address common infections, maternal and child health needs, and basic treatments.
At the secondary care level, approximately 628 medicines support more specialized treatments in community and district hospitals.
At the tertiary care level, around 1,475 items support advanced treatment, surgeries, and complex diagnostic procedures in medical colleges and higher level hospitals.
Focus on Cardiac Care and Cancer Treatment
Many of the newly added medicines target high priority disease areas. A large portion of additions focus on cardiovascular diseases and cancer treatment, reflecting the growing burden of non communicable diseases in India.
Including newer and more effective medicines ensures that patients can access modern treatment options through the public healthcare system.
Impact on Public Healthcare in Gujarat
The expanded drug list supports Gujarat’s broader healthcare initiatives aimed at improving universal health coverage. Programs such as the Mukhyamantri Amrutam scheme and the state’s free medicine and diagnostic services benefit from these updates.
For patients, particularly those in rural and underserved areas, the revised list means better access to essential medicines without additional financial burden. For the healthcare system, it improves procurement efficiency and ensures consistent drug availability across government facilities.
